Psychology Today Here to Help
Search:

Depression Health Center

Font Size
A
A
A

FDA OKs New Antidepressant Pristiq

Pristiq Is a Modified Form of the Antidepressant Effexor XR
By Miranda Hitti
WebMD Health News
Reviewed by Louise Chang, MD

March 3, 2008 -- The FDA has approved Pristiq, a new antidepressant that's a modified version of the antidepressant Effexor XR, for the treatment of major depressive disorder in adults.

Pristiq and Effexor XR are made by Wyeth .

Pristiq, which is taken once daily and isn't approved for pediatric patients, will be available in the second quarter of 2008, Wyeth notes.

Pristiq belongs to a class of drugs called serotonin norepinephrine reuptake inhibitors (SNRIs). According to Wyeth, the FDA approved Pristiq based on four studies in which Pristiq trumped a placebo pill at treating major depressive disorder in adults.

Pristiq has also been studied as a treatment for menopausal hot flashes and night sweats. But so far, the drug has only been approved for depression treatment.

View Article Sources Sources
© 2008 WebMD, LLC. All rights reserved.

Are You Seeking Better Seizure Control?
Vimpat
Are You Seeking Better Seizure Control?

Important Safety Information

Vimpat (lacosamide) is a medicine that is used with other medicines to treat partial onset seizures in patients 17 years of age and older with epilepsy. Vimpat is generally well-tolerated, but may not be for everyone. Ask your doctor if Vimpat is right for you. Antiepileptic drugs, including Vimpat, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before. Please see additional patient information in the Medication Guide at the end of the full prescribing information. This information does not take the place of talking with your healthcare provider about your condition or your treatment. Please see additional Patient Safety Information

Medication Guide